Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Immunology

Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Alabama

Children's Hospital of Alabama
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

California

Children's Hospital of Orange County
Orange California 92868

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

University of California San Francisco Medical Center - Parnassus
San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

District of Columbia

Children's National Medical Center
Washington District of Columbia 20310

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Georgia

Children's Healthcare of Atlanta-Egleston
Atlanta Georgia 30307

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Illinois

Northwestern University
Chicago Illinois 60611
Updated

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago Illinois 18150

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Indiana

Riley Hospital for Children
Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical research study of bortezomib and rituximab for the treatment of Post-transplant Lymphoproliferative Disease, Solid Organ Transplant, Stem Cell Transplant (Bone Marrow Transplant) or Epstein Barr Virus Infections

Tufts University School of Medicine
Boston Massachusetts 02111
Updated

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Michigan

C S Mott Children's Hospital
Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Minnesota

University of Minnesota Cancer Center-Fairview
Minneapolis Minnesota 55435

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Missouri

Washington University School of Medicine
St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

New York

Columbia University Medical Center
New York New York 10032

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Ohio

Cincinnati Children's Hospital Medical Center
Cincinnati Ohio 45229

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Rainbow Babies & Children's Hospital
Cleveland Ohio 44106

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Pennsylvania

Children's Hospital of Philadelphia
Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Children's Hospital of Pittsburgh of UPMC
Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Tennessee

Saint Jude Children's Research Hospital
Memphis Tennessee 38105

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Texas

Baylor College of Medicine
Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

UT MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Washington

Seattle Children's Hospital
Seattle Washington 98105

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Wisconsin

Midwest Children's Cancer Center
Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Czech Republic

Hospital Motol
Prague

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

First Faculty of Medicine, Charles University in Prague
Praha Prague

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z.
Usti nad Labem

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

France

Institut Bergonié
Bordeaux

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Hôpital Huriez
Lille

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Hôpital Edouard Herriot
Lyon

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Hôpital Rangueil
Toulouse

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Germany

Universitätsklinikum Aachen
Aachen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Heinrich-Heine University
Düsseldorf

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Universitätsklinikum Tübingen
Tübingen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Italy

Università Vita e Saluta
Milano

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Universitaria Pisana
Pisa

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Japan

Chuo-ku Tokyo

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

National Cancer Center Hospital
Chuo-ku, Tokyo

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Kyushu University Hospital
Hukuoka-shi Hukuoka

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Isehara Kanagawa

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

Kashiwa Chiba

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

View More »

The Cancer Institute Hospital Japanese Foundation for Cancer Research
Koto Tokyo

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

The University of Tokyo, The Institute of Medical Science
Minato-ku Tokyo

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Nagoya Aichi

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

Japan Red Cross Daiichi Hospital
Nagoya-shi Nagoya

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Osaka City University Hospital
Shinjuku-ku Tokyo

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Keio University Hospital
Shinjuku-ku Tokyo

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Tokyo Medical University Hospital
Shinjuku-ku, Tokyo

Patients are needed to participate in a clinical research study evaluating ponatinib - Phase 1 and ponatinib - Phase 2 for the treatment of Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Malaysia

University Malaya Medical Centre
Kuala Lumpur

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Netherlands

NKI
Amsterdam

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

St Antoniusziekenhuis
Nieuwegein

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

First 1 2 Last